STAT6d
Q&A: How the FDA is approaching AI in clinical trials and drug development
The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.
The Tribune-Democrat4dOpinion
Andrei Iancu and David Kappos | Proposed drug patent reforms would do more harm than good
Congress is considering a bill that could exacerbate government waste and give American companies’ most valuable trade ...
Business Wire17d
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
today announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults.
Austin American-Statesman15d
FDA issues recalls on at least 16 food and drug items in September. Here's a list
This could be due to U.S. Food and Drug Administration recalls. The FDA has continued to suspend food and drug items that people might typically buy. Here is a list of September food and ...
NBC New York19d
FDA issues recall notices over 2 brands of pet food due to salmonella and listeria risk
Amid an ongoing pet food recall, the U.S. Food and Drug Administration (FDA) is urging pet owners not to give their ...
JD Supra7d
GLP-1 Drugs: FDA Removes Lilly’s Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Shortage List
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
agdaily6d
10 careers in food science: Driving innovation and sustainability in the food industry
Careers in food science not only focus on improving food quality but also on addressing challenges like food security, waste ...
WHYY5d
Philadelphia health providers and patients seek a new treatment roadmap for sickle cell disease after drug recall
Voxelotor, which was sold under the brand name Oxbryta, was suddenly pulled from the market over safety concerns from ...
SCOTUSblog11d
Food and Drug Administration v. R.J. Reynolds Vapor Co.
Issue: Whether a manufacturer may file a petition for review in a circuit (other than the U.S. Court of Appeals for the District of Columbia Circuit) where it neither resides nor has its principal ...
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...